LRP1 and neoplasm: In addition we have recently shown that CD91/LRP-1 serves as a signaling receptor for HSPs [26] and now we show here that the same is true for α2M. While prophylactic responses against tumor challenges are usually observed following priming of T cell responses with numerous reagents, therapeutic responses are much more difficult to achieve and in most cases actually fail.